Stay updated on Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial
Sign up to get notified when there's something new on the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page.

Latest updates to the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has been updated to reflect a new version number, changing from v2.14.4 to v2.15.0. Additionally, a reference to the Pfizer CT.gov Call Center has been removed.SummaryDifference0.3%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 21, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.2%
- Check36 days agoNo Change Detected
- Check72 days agoChange DetectedThe webpage has updated its last update date to February 21, 2025, and removed previous update dates, indicating a shift in the timeline of information presented.SummaryDifference1%
- Check86 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
Stay in the know with updates to Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page.